Influenza diagnostics comprises of a number of flu tests that are used to detect influenza viruses in respiratory specimens. The most common are called “rapid influenza diagnostic tests."The rapid influenza diagnostic tests" work by detecting the parts of the virus (antigens) that stimulate an immune response.
The market of influenza diagnostics market is anticipated to grow with a significant rate in the coming years, owing to factors such as, increasing prevalence and incidence of influenza, rising demand for faster diagnostic test for influenza, increasing number of patients acquiring infections. Various technological improvements and approval of new diagnostic tests in the healthcare industry in Asia Pacific and Europe are expected to offer growth opportunities for the players operating in the market.
The “Global Influenza Diagnostics Market Analysis to 2025” is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report for influenza diagnostics market aims to provide an overview of global Influenza diagnostics market with detailed market segmentation by type, end user and geography. The global influenza diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global influenza diagnostics market is segmented on the basis of type, end user and geography. On the basis of type, the influenza diagnostics market is segmented into molecular diagnostic tests, traditional diagnostic tests. Based on end user, the influenza diagnostics market is segmented into reference laboratories, hospitals/clinical laboratories and other end users.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global influenza diagnostics market based on type, end user and geography. It also provides market size and forecast till 2025 for overall influenza diagnostics market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America is expected attain the largest share in the Influenza diagnostics market in the coming years, owing to factors such as, improved infrastructure of healthcare, technological advancement in diagnostic techniques, rising expenditure in healthcare sector, growing prevalence of chronic disorders in United States and Canada. Asia Pacific is expected to witness significant growth rate during the forecast period primarily due to the implementation of new technologies, awareness about influenza among people in Asian countries such as, India, China and Japan.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key influenza diagnostics market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Abbott, Thermo Fisher Scientific, Inc., F. Hoffmann La-Roche, Ltd., Quidel Corporation, BD, DiaSorin S.p.A., Luminex Corporation, SA Scientific, Sekisui Diagnostics and Meridian Bioscience, Inc. among others.